(Adnkronos) – “Gilead's commitment, made of dedication and innovation, has been going on for over 30 years and is to transform the natural course of pathologies by bringing innovative therapies to patients. With the recent acquisition of CimaBay the commitment is also expanding to areas other than infectious disease to enter a more immunological area of expertise”. Thus Carmen Piccolo, medical director of Gilead Sciences Italia, on the occasion of the AISF Congress on viral hepatitis at the Auditorium della Tecnica Congress Center in Rome.
#Piccolo #39Gilead #expands #infectivity #immunology
The Mediterranean diet saves women, the risk of death collapses
The Mediterranean diet reduces the risk of mortality in women. The latest research in chronological order to delve into the...